Ms Margaret Ann Sohar, | |
29 Institute Ln, # 10, N Scituate, RI 02857-1424 | |
(401) 301-2587 | |
Not Available |
Full Name | Ms Margaret Ann Sohar |
---|---|
Gender | Female |
Speciality | Occupational Therapist - Pediatrics |
Location | 29 Institute Ln, N Scituate, Rhode Island |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1699940510 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
225XP0200X | Occupational Therapist - Pediatrics | PT00115 (Rhode Island) | Primary |
Mailing Address | Practice Location Address |
---|---|
Ms Margaret Ann Sohar, 29 Institute Ln, # 10, N Scituate, RI 02857-1424 Ph: (401) 301-2587 | Ms Margaret Ann Sohar, 29 Institute Ln, # 10, N Scituate, RI 02857-1424 Ph: (401) 301-2587 |
News Archive
"Insurance companies, unions, medical device makers and others in the health care industry are furiously lobbying lawmakers to shift burdens onto someone else — anyone else — before they find themselves saddled with billions of dollars in taxes under new health care legislation," The Associated Press reports.
Officials will launch a marketing campaign in conjunction with the NCAA college basketball tournaments - events they view as offering great potential for reaching young people and urging them to get health insurance.
In his article, "Pathoetiology of multiple sclerosis: are we barking up the wrong tree?", Peter K. Stys of the Hotchkiss Brain Institute, University of Calgary, argues that while the majority of the medical research community currently approaches MS as an autoimmune disease (much like Lupus and Rheumatoid Arthritis), for which the trigger is the immune system attacking a particular part of the nervous system, the features of the disease are equally well explained by approaching MS as a neurodegenerative disease (such as Parkinson's and Alzheimer's), which is followed by an immune reaction to damage.
Xenomics, Inc. a developer of trans-renal molecular diagnostic technologies, announced today that it has filed a complaint against Sequenom, Inc. in the Supreme Court of the State of New York alleging that Sequenom fraudulently misrepresented to Xenomics the status of its testing for Down Syndrome and based upon such conduct, Xenomics was induced to enter into a license agreement with Sequenom thereby giving up various valuable patent rights.
According to health experts, pregnant women and newborns should be screened for a virus that causes brain damage and deafness. The study that appeared in the latest issue of The Medical Journal of Australia yesterday says hundreds of cases of cytomegalovirus (CMV) are likely being missed each year in Australia because of a lack of screening, denying babies treatment for the condition.
› Verified 1 days ago